Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational Study of Its Kind ...


- 31 Août 2016 modifié le 1 Janvier 1970


(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that its global non-interventional, observational multiple myeloma study is now enrolling patients. Titled INSIGHT-MM, the study aims to enroll 5,000 patients over three years with a goal of following each patient for a minimum of five years in an effort to track patterns in disease presentation, patient characteristics, treatment and outcomes and thereby enhance the understanding of real world experience of patients with multiple myeloma.

“As both a physician and a patient, I have seen – and experienced – rapid changes in the approach to multiple myeloma treatment. ...

Source : http://me-newswire.net//news/18562/en...



ACTUALITES | INTERNATIONAL | TCHAD | POLITIQUE | CULTURE | EXCLUSIF | Revue de Presse | English News | 中國